Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC005189 | Panoply™ Human FABP4 Knockdown Stable Cell Line | Inquiry |
| CSC-SC005189 | Panoply™ Human FABP4 Over-expressing Stable Cell Line | Inquiry |
| CLOE-2555 | Mouse Fabp4 HEK293 Cell Lysate | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD00166Z | Human FABP4 adenoviral particles | Inquiry |
| AD05708Z | Human FABP4 adenoviral particles | Inquiry |
| LV12104L | human FABP4 (NM_001442) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH044075 | shRNA set against Rat Fabp4(NM_053365.1) | Inquiry |
| SHH044039 | shRNA set against Human FABP4(NM_001442.2) | Inquiry |
| SHH044057 | shRNA set against Mouse Fabp4(NM_024406.2) | Inquiry |
| SHH288629 | shRNA set against Human FABP4 (NM_001442.2) | Inquiry |
| SHH288633 | shRNA set against Mouse FABP4 (NM_024406.2) | Inquiry |
| SHH288637 | shRNA set against Rat FABP4 (NM_053365.1) | Inquiry |
| SHW004806 | shRNA set against Chicken FABP4 (NM_204290) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCL184147 | Human FABP4 ORF clone(NM_001442.2) | Inquiry |
| CDFR013119 | Rat Fabp4 cDNA Clone(NM_053365.1) | Inquiry |
| MiUTR1H-03371 | FABP4 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-04556 | FABP4 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-01809 | FABP4 miRNA 3'UTR clone | Inquiry |
| CDCB166281 | Chicken FABP4 ORF Clone (NM_204290) | Inquiry |
| CDCB195497 | Rabbit FABP4 ORF clone (XM_002710655.2) | Inquiry |
| CDCL184148 | Mouse FABP4 ORF clone(NM_024406.2) | Inquiry |
| CDCR380206 | Rat Fabp4 ORF Clone(NM_053365.1) | Inquiry |
| CDCS410277 | Human FABP4 ORF Clone (BC003672) | Inquiry |
Fatty acid-binding proteins (FABPs) are a group of homologous low molecular weight intracellular lipid-binding proteins. Its molecular weight is 14-15 kD and contains 125-134 amino acids. It can be used as a fat molecular chaperone to participate in the transport of fatty acids in cells and other signal transduction pathways. FABP4 is one of the most characteristic intracellular lipid transporters in the FABPs family, and plays a central regulatory role in energy metabolism and inflammation.
FABP4 is mainly expressed in adipocytes, macrophages, dendritic cells and microvascular endothelial cells. The functions of FABP4 are as follows.
Figure 1. Schematic view recapitulating the involvement of endothelial FABP4 in liver carcinogenesis related to metabolic syndrome. (Laouirem, S., et al. 2019)
Studies have confirmed that IL-4 mediated STAT6 signal transduction in airway epithelial cells leads to downstream FABP4 gene expression; Th2 cytokines IL-4 and IL-13 up-regulate FABP4 expression; Th1 cytokine IFN-γ down-regulates FABP4 expression. The results of this study indicate that FABP4 expression in airway epithelial cells depends on STAT6 signal transduction, and FABP4 participates in Th2 cell response. STAT6 is a transcription factor that plays a major regulatory role in allergic inflammation. It transduces the cytokines IL-4 and IL-13 through the JAK/STAT signaling pathway to mediate airway inflammation and airway hyperresponsiveness in asthma. Therefore, FABP4 may be closely related to the occurrence and development of asthma.
Another study found that the staining intensity of FABP4 in airway epithelial cells in a mouse model of allergic airway inflammation was more significant than that in wild-type mice. In mouse asthma models induced by ovalbumin sensitization and airborne allergens, FABP4 knockout mice had significantly fewer inflammatory cells in bronchoalveolar lavage fluid than wild-type mice. In addition, the levels of cytokines IL-5 and IL-13 are significantly reduced, and inflammation around the bronchus and blood vessels is also significantly reduced.
EMT refers to the biological process of epithelial cells transforming into cells with mesenchymal phenotype under specific physiological or pathological conditions. FABP4 overexpression is associated with hyperlipidemia. Studies have confirmed that hyperlipidemia is very likely to cause hypoxia, and hypoxia-inducible factor-α in the hypoxic microenvironment in tumors exerts its activity. It up-regulates Snail by regulating the transcription of downstream target genes such as zinc finger transcription factor Snail, vimentin, epithelial cadherin, and nuclear factor κB, thereby reducing the level of epithelial cadherin and promoting tumor invasion and metastasis, such as liver cancer, pancreatic cancer, etc.
References: